Skip to main content

7775 · DAIKEN MEDICAL CO.,LTD · Financials

411 JPY +0 (+0.00%) At close · Nov 13
Market Cap
11.81B JPY
Shares
28.73M
Volume · Nov 13 54K Avg daily vol (3M) 30.53K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
10.29B +3.4%
FY2026 Revenue FY2022–FY2026
Net Income
922.64M -15.9%
FY2026 Net Income FY2022–FY2026
Gross Margin
38.4% -2.8pp
FY2026 Gross Margin FY2022–FY2026
Operating Margin
12.41% -2.8pp
FY2026 Operating Margin FY2022–FY2026
Operating Cash Flow
567.71M -49.4%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 FY2025 FY2024 FY2023 FY2022
JPY 10.29B 9.95B 9.75B 9.14B 8.54B
JPY 6.34B 5.85B 5.77B 5.61B 4.86B
JPY 3.95B 4.1B 3.98B 3.53B 3.68B
JPY 1.28B 1.51B 1.44B 1.05B 1.15B
JPY 1.25B 1.51B 1.44B 1.03B 1.15B
JPY 323.47M 410.81M 447.86M 312.96M 320.28M
JPY 922.64M 1.1B 988.6M 712.06M 831.06M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 2.99B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.